Page 104 - Puneet Wadhwa

Infra stocks crack; analysts favour selective buying

Analysts suggest that formation of a stable government post the upcoming General Elections is likely to positively impact the construction sector

FOMC taper: Bumpy road ahead for emerging markets?

Most Asian markets crack. Rupee under pressure

5 reasons why Maruti's move is a strategic mis-step

Here are 5 reasons why analysts think the latest development is a significant strategic mis-step

Despite decline, Indian markets outperform Asian peers in 2014

Corrective decisions taken by the Reserve Bank of India (RBI) in managing the currency from slipping further aided sentiment

Analysts' View: RBI's Monetary Policy review

Check out what the experts say

Tech View: Karl Slym dies in Bangkok. Should you dump Tata Motors?

The stock has tanked over 4% in trade today post the development. Tata Motors hired Slym was in 2012 to revive flagging sales and market share in the domestic business of the company

Ranbaxy in US FDA trouble, again; stock skids 18%

The markets have given a thumbs-down to the development with Ranbaxy skidding 18% to Rs 343 levels in morning trades on the National Stock Exchange (NSE)

Better days ahead for L&T and HDFC?

While L&T has moved up 3.2% to Rs 1,037 levels on the Bombay Stock Exchange (BSE) in morning deals, HDFC has gained nearly 1% on the National Stock Exchange (NSE) to Rs 848 levels

Investors more optimistic about global growth: BofA-Merrill Lynch

Biggest tail-risk to global growth remains China hard landing and commodity collapse. Investors maintain underweight stance on India

LIC churns portfolio in December quarter

Pulls out mainly from private companies; select PSUs saw the insurer raise its stake

Small, mid-cap stocks see heavy FII buying

Stakes raised significantly in select companies during Dec quarter, pushing sectoral indices up more than larger peers

LPG cap hike sees OMC stocks bleed

Investors give a thumbs-down to the populist move of hiking LPG cylinder cap with HPCL, BPCL and IOC losing ground in trade

Volume growth in pharma space rebounds in December

Ipca Labs, Glenmark, Sun Pharma lead domestic market growth. Momentum likely to continue in near-to-medium term, analysts say

ITC: Results in-line with Street estimates

ITC offers the best earnings visibility in the sector especially when sector peers are confronting multiple challenges, analysts say

Result Impact: HCL Technologies hits record high; time to exit?

The stock was up over 3% at Rs 1,378 on the Bombay Stock Exchange.

Metal stocks rally; should you invest?

The rally was partly boosted by a World Bank report that expects the global economy to expand at 3.2% in 2014 as compared to 2.4% in 2013

Volume growth in pharma space rebounds in December

IPCA Laboratories, Glenmark Pharma and Sun Pharma lead December 2013 domestic growth

Companies tap lower valuations to launch buybacks

Buybacks aggregating Rs 7,800 crore announced since August, against Rs 1,000 crore during January-July

US Fed may complete tapering by late summer: Kunal Kumar Kundu

Q&A with vice-president and India economist, Societe Generale

QE taper, general elections key for markets in 2014

Top picks - Aurobindo Pharma, Bajaj Finance, Cairn India, Coal India, J.B. Chemicals M&M, Mastek, Max India, RIL and Sesa Sterlite.